Clinical Trials in Prostatic Cancer: Methodology and Controversies
- 1 January 1987
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- A randomized study of doxorubicin versus doxorubicin plus cisplatin in endocrine-unresponsive metastatic prostatic carcinomaCancer, 1985
- The flare phenomenon on radionuclide bone scan in metastatic prostate cancerAmerican Journal of Roentgenology, 1984
- Carcinoma of the prostate: Relationship of pretreatment hormone levels to survivalEuropean Journal of Cancer and Clinical Oncology, 1984
- Urinary hydroxyproline levels in patients with prostatic carcinomaInternational Urology and Nephrology, 1983
- A comparative clinical trial of adriamycin and 5‐fluorouracil in advanced prostatic cancer: Prognostic factors and responseThe Prostate, 1983
- The importance of the stable category for chemotherapy treated patients with advanced and relapsing prostate cancerCancer, 1980
- Urinary Hydroxyproline Excretion in Carcinoma of the Prostate. A Comparison of 4 Different Modes of Assessment and its Role as a MarkerBritish Journal of Urology, 1979
- The Treatment of Oestrogen-Escaped Carcionoma of the Prostate with Estramustine PhosphateBritish Journal of Urology, 1977
- Evaluation of Response-Time Data Involving Transient States: An Illustration Using Heart-Transplant DataJournal of the American Statistical Association, 1974
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentJournal of Chronic Diseases, 1961